CVS Group (LON:CVSG) Price Target Raised to GBX 1,400

CVS Group (LON:CVSG) had its price target boosted by Jefferies Financial Group from GBX 1,350 to GBX 1,400 in a research note issued on Friday,Digital Look reports. The firm currently has a “hold” rating on the stock. Jefferies Financial Group’s target price would suggest a potential upside of 9.55% from the stock’s previous close.

A number of other research firms also recently weighed in on CVSG. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,700 price target on shares of CVS Group in a research note on Monday. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 2,000 price objective on shares of CVS Group in a research note on Thursday, July 23rd. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of GBX 1,720.

CVS Group Stock Performance

CVS Group stock opened at GBX 1,278 on Friday. The company has a market cap of £884.38 million, a PE ratio of 18.55, a PEG ratio of 1.77 and a beta of 1.06. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 92.34. CVS Group has a 1 year low of GBX 1,062 and a 1 year high of GBX 1,648. The company’s 50-day moving average is GBX 1,228.63 and its two-hundred day moving average is GBX 1,244.87.

CVS Group announced that its board has approved a share repurchase plan on Tuesday, May 26th that authorizes the company to repurchase 0 shares. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its stock is undervalued.

Insiders Place Their Bets

In related news, insider Scott Morrison bought 987 shares of CVS Group stock in a transaction on Wednesday, May 27th. The shares were purchased at an average price of GBX 1,270 per share, for a total transaction of £12,534.90. Insiders own 1.43% of the company’s stock.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.